# Outcomes of Rivaroxaban and Aspirin in PAD After Endovascular Revascularization

> **NCT05308030** · EARLY_PHASE1 · UNKNOWN · sponsor: **Assiut University** · enrollment: 100 (estimated)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DRUG:** Rivaroxaban and Aspirin

## Key facts

- **NCT ID:** NCT05308030
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-01
- **Primary completion:** 2023-05
- **Final completion:** 2023-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05308030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05308030, "Outcomes of Rivaroxaban and Aspirin in PAD After Endovascular Revascularization". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05308030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*